Clinical trial
ETDRS Panretinal Photocoagulation (PRP) Combined With Intravitreal Ranibizumab (IVR) Versus Retinal Photocoagulation Targeted to Ischemic Retina Combined With IVR for the Treatment of Proliferative Diabetic Retinopathy
NCT03904056 is registered in ClinicalTrials.gov with São Paulo State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ETDRS Panretinal Photocoagulation (PRP) Combined With Intravitreal Ranibizumab (IVR) Versus Retinal Photocoagulation Targeted to Ischemic Retina Combined With IVR for the Treatment of Proliferative Diabetic Retinopathy
- Lead sponsor
- São Paulo State University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2014
- Completion date
- July 1, 2017
- Enrollment
- 23 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.